Mallinckrodt will acquire Sucampo Pharmaceuticals’ commercial and development assets for approximately $1.2 billion, pending regulatory approval.
Recent SEC filings provided insights into Exact Sciences, the company that manufactures Cologuard, finding President and CEO Kevin Conroy sold 245,362 shares for a total of $13 million.
Pentax Medical launched its C.A.P. HD Duodenoscope in the U.S.; it is the first duodenoscope with a disposable distal cap.
More articles on gastroenterology:
Mallinckrodt acquiring Sucampo Pharmaceuticals for $1.2B — 4 insights
Exact Sciences CEO sells $6.5M — Hedge funds hold 84.5% of company: 4 insights
GI leader to know: Dr. Arthur Berman of Florida Center for Gastroenterology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.